ArticleDiabetes, obesity & metabolism2026
Trends in Potentially Avoidable Hospitalisations Among People With Diabetes in Ireland; 2015-2024.
Article in Diabetes, obesity & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Trends in Potentially Avoidable Hospitalisations Among People With Diabetes in Ireland; 2015-2024.Diabetes, obesity & metabolism · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
aimTo examine trends in potentially avoidable hospitalisations (PAHs) among people with diabetes in Ireland between 2015 and 2024, and how trends differ by sex and diabetes type. MATERIAL AND
methodsUsing national hospitalisation data from the Republic of Ireland, we estimated rates and trends in PAHs among people with diagnosed type 1 or type 2 diabetes between 2015 and 2024, during which 181 130 PAHs occurred. This included 21 complications, which were used to create a composite measure. We also grouped these into five condition groups including diabetes-specific, cardiovascular-related, infection, lower extremity and acute kidney failure. We calculated age-standardised rates (ASRs) and assessed temporal trends using linear time-trend models and Joinpoint regression analysis.
resultsASRs decreased from 105.0 (95% CI: 100.4, 109.2) per 1000 people with diabetes in 2015 to 91.0 (95% CI: 87.7, 94.3) in 2024 with an average decline of 2.5% (95% CI: -3.1, 1.7) per year. ASRs were consistently higher among individuals with type 1 diabetes compared with those with type 2 diabetes (p < 0.001). When examined by condition group, ASRs declined steadily over time for all except those relating to infections, which showed an increase from 2022 onwards.
conclusionAlthough PAHs declined over the study period, rates remained high especially among people with type 1 diabetes. The shifting profile of PAHs towards non-diabetes-specific conditions highlights emerging prevention challenges and the need to strengthen primary and community-based care pathways for people living with diabetes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.